Cover Image

In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta

Objective: To study the impact of follitropin delta for ovarian stimulation on embryo development and quality compared with that of follitropin alfa or beta in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles. Design: Retrospective cohort study Setting: University-affiliated...

Full description

Saved in:

Bibliographic Details
Main Authors:	Olga Haakman, M.D (Author), Tina Liang, M.D (Author), Kristen Murray, B.Sc (Author), Angelos Vilos, M.D (Author), George Vilos, M.D (Author), Carlee Bates, Ph.D (Author), Andrew J. Watson, Ph.D (Author), Michael R. Miller, Ph.D (Author), Basim Abu-Rafea, M.D (Author)
Format:	Book
Published:	Elsevier, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Follitropin Alpha versus Follitropin Beta in IVF/ICSI Cycle: A Retrospective Cohort Study
by: Cao JX, et al.
Published: (2024)

An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data
by: D. P. Kamilova, et al.
Published: (2021)

Advisory Board on potential import substitution of follitropin alfa preparations in IVF cycles
by: article Editorial
Published: (2021)

Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
by: Matthieu Lehmann, et al.
Published: (2024)

Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)
by: Z. B. Barakhoeva, et al.
Published: (2018)

Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies
by: K. A. Perova, et al.
Published: (2022)

A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro
by: Naiel Azzam, et al.
Published: (2021)

A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
by: Schneider Danielle T, et al.
Published: (2009)

Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis
by: Stefano Palomba, et al.
Published: (2024)

Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022
by: D. G. Shchurov, et al.
Published: (2023)

A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France."
by: Juan-Enrique Schwarze, et al.
Published: (2024)

Comparing a biosimilar follitropin alfa (Cinnal-fⓇ ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT
by: Batool Hossein Rashidi, et al.
Published: (2021)

Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
by: Bühler K
Published: (2015)

Ovulation induction with minimal dose of follitropin alfa: a case series study
by: Menabrito Marco, et al.
Published: (2011)

How to dose follitropin delta for the first insemination cycle according to the ESHRE and ASRM guidelines; a retrospective cohort study
by: Suha Arab, et al.
Published: (2023)

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment
by: Agostinetto Rita
Published: (2009)

Impact of class III obesity on outcomes and complications of transvaginal ultrasound-guided oocyte pickup
by: Tina Liang, M.D, et al.
Published: (2020)

Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
by: Matthieu Lehmann, et al.
Published: (2024)

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
by: Gizzo S, et al.
Published: (2016)

Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination
by: I. S. Krysanov, et al.
Published: (2023)

Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study
by: Oscar Barbosa Duarte-Filho, et al.
Published: (2024)

Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection
by: Rui Yang, et al.
Published: (2022)

Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats
by: Ezcurra Diego, et al.
Published: (2008)

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency
by: Rinaldi L, et al.
Published: (2016)

THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017
by: I. I. Vorobiev, et al.
Published: (2017)

Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol
by: Manuel Fernández Sánchez, et al.
Published: (2023)

Continuous ovarian stimulation: a proof-of-concept study exploring the uninterrupted use of corifollitropin α in DuoStim cycles for enhanced efficiency and patient convenience (Alicante protocol)
by: Juan Carlos Castillo, M.D., Ph.D, et al.
Published: (2024)

Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
by: Welcker J, et al.
Published: (2010)

Conventional follicular-phase ovarian stimulation vs. luteal-phase stimulation in suboptimal responders: a randomized controlled trial
by: Jorge Suñol, M.D, et al.
Published: (2023)

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series
by: Stephanie Yacoub, et al.
Published: (2021)

Highly purified human-derived follicle-stimulating hormone (Bravelle®) has equivalent efficacy to follitropin-beta (Follistim ®) in infertile women undergoing in vitro fertilization
by: Webster Bobby W, et al.
Published: (2003)

Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
by: Su Jen Chua, et al.
Published: (2021)

Follicular phase length is not related to live birth outcome in women with unexplained infertility undergoing ovarian stimulation with intrauterine insemination cycles in a multicenter trial
by: Pardis Hosseinzadeh, M.D, et al.
Published: (2023)

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
by: Christos A. Venetis, et al.
Published: (2023)

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
by: Xue W, et al.
Published: (2019)

A PEN INJECTOR FOR SELF-ADMINISTRATION OF FOLLITROPIN ALPHA SOLUTION WITH A MINIMAL DOSE INCREMENT OF 5 IU
by: A. B. Podkorytov, et al.
Published: (2018)

Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study
by: Peter Sydow, et al.
Published: (2020)

Subcutaneous progesterone administration provides a similar ongoing pregnancy rate compared with intramuscular progesterone administration in hormone replacement therapy frozen embryo transfer cycles
by: Fazilet K. Boynukalin, M.D., MSc, et al.
Published: (2023)

Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation
by: Rachel B. Danis, M.D., M.S, et al.
Published: (2021)

Novel inactivating follicle-stimulating hormone receptor mutations in a patient with premature ovarian insufficiency identified by next-generation sequencing gene panel analysis
by: Asma Sassi, M.D, et al.
Published: (2020)